NEOADJUVANT THERAPY
Clinical trials for NEOADJUVANT THERAPY explained in plain language.
Never miss a new study
Get alerted when new NEOADJUVANT THERAPY trials appear
Sign up with your email to follow new studies for NEOADJUVANT THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise in shrinking lung tumors before surgery
Disease control OngoingThis study tests a new drug called ivonescimab in people with non-small cell lung cancer who need surgery. The drug is given before surgery to shrink tumors and make them easier to remove. Researchers want to see if it works better than standard treatments and learn how it helps …
Matched conditions: NEOADJUVANT THERAPY
Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated May 17, 2026 00:51 UTC
-
New drug combo shows promise for advanced throat cancer
Disease control OngoingThis study tests whether adding an immunotherapy drug (PD-1 inhibitor) to chemotherapy before standard treatment can help people with advanced nasopharyngeal cancer live longer without the disease getting worse. About 150 adults with stage T4 or N2-3 cancer will receive either th…
Matched conditions: NEOADJUVANT THERAPY
Phase: PHASE2 • Sponsor: Guangxi Medical University • Aim: Disease control
Last updated May 17, 2026 00:51 UTC
-
New drug combo shows promise in shrinking lung tumors before surgery
Disease control OngoingThis study looks at whether giving the drug serplulimab together with chemotherapy before surgery can help people with a certain type of lung cancer (non-small cell lung cancer). The goal is to shrink tumors and make surgery more effective, possibly reducing the chance of cancer …
Matched conditions: NEOADJUVANT THERAPY
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated May 17, 2026 00:50 UTC
-
Chemo before surgery may boost cancer fight
Disease control OngoingThis study compares two treatments for high-risk upper tract urothelial cancer: chemotherapy followed by surgery versus surgery alone. About 120 adults with localized cancer will take part. The goal is to see if adding chemotherapy before surgery helps shrink tumors and improve l…
Matched conditions: NEOADJUVANT THERAPY
Phase: PHASE2 • Sponsor: Changhai Hospital • Aim: Disease control
Last updated May 17, 2026 00:46 UTC
-
Promising combo may boost esophageal cancer surgery success
Disease control OngoingThis study tests whether adding the drug serplulimab to standard chemotherapy before surgery can help people with esophageal cancer. The goal is to see if this combination can shrink tumors more effectively and lower the chance of cancer coming back after surgery. About 48 adults…
Matched conditions: NEOADJUVANT THERAPY
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated May 17, 2026 00:44 UTC
-
New combo aims to shrink tough colon cancers before surgery
Disease control OngoingThis study tests whether adding the immunotherapy drug tislelizumab to standard chemotherapy before surgery can help people with a common type of colon cancer (MSS, locally advanced). About 60 adults will receive the combination, then have surgery to remove the tumor. The main go…
Matched conditions: NEOADJUVANT THERAPY
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Disease control
Last updated May 15, 2026 12:07 UTC